SD HEALTHCARE
Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Evofem at Critical Stretch with Potential New Birth Control
BIOTECH: Contraceptive Gel Is Part of CEO's Health Mission for WomenEvofem Biosciences wants to be the next big thing in birth control. After a long road, the San Diego biotech finds itself in a pivotal stretch.Cradle Genomics Lands $17.1M Series A Round for Prenatal Testing
A startup led by former Illumina executives that wants to advance prenatal testing recently landed a $17.1 million series A round.
Trefoil Therapeutics Secures $28M Series A Round
San Diego biotech Trefoil Therapeutics recently brought in a $28 million series A round for work on vision diseases.
Analysts Stick By Illumina After Stock Sell-Off
Illumina analysts are still bullish on the company after a lowered revenue estimate prompted a stock sell-off.
StemoniX’s Growth Pushes It Into New Larger Facility
Its microOrgan Platform Provides More Human-Like Testing Opportunities
StemoniX — a San Diego biotech that grows micro organs from stem cells for drug testing — moved into a larger research facility this month.
Scripps Research Leading International Partnership For HIV Vaccine
NIH Division Will Provide Grant of $129 Million
An international partnership led by Scripps Research on July 10 pulled in a $129 million grant to bring a potential HIV vaccination into clinical testing.
These San Diego Biotechs Fell Hard, But Managed to Bounce Back
Biotechs recover momentum after being written off
Once pegged as goners, San Diego life sciences companies like Neurocrine, Arena Pharmaceuticals and Tandem Diabetes Care made comebacks. Their stories shed light on how to weather an industry in which companies expand and contract like an accordion based on clinical trial results.
Startups Claim Slice of a Changing Medical Device Market
HEALTH: $800 Billion Market Is Expected By 2030
The news coming out of San Diego’s medical device scene usually centers on the big dogs: Dexcom, ResMed and Nuvasive.
UC Board of Regents To Receive $50M in Settlement From USC
It Was Alleged That School Poached Research Program; USC Admits Ethics Lapses
The University of Southern California will pay UC San Diego $50 million to settle a lawsuit that alleged USC improperly commandeered an Alzheimer’s
Parkinson’s Disease Drug from Neurocrine Accepted for U.S. Review
The U.S. Food and Drug Administration will consider giving marketing approval to Neurocrine Biosciences’ drug for Parkinson’s disease.
Illumina Shares Fall on Lower Revenue Expectations
Illumina’s stock fell 16% in after-hours trading after the company reduced its revenue expectations for the second quarter and the rest of 2019.
Scripps-Led Effort Receives $129M Grant for HIV Vaccine
An international partnership led by Scripps Research on July 10 pulled in a $129 million grant to bring a potential HIV vaccination into clinical testing.
Ra Medical Addresses Manufacturing Issues
BIOTECH: Legal Battle Is Ahead For Company
After a $66.3 million initial public offering in September of 2018, Ra Medical Systems has tumbled.
Dementia Work Earns Bioengineer Recognition
Hsu Expands Gene Editing To RNA
A bioengineer at the Salk Institute for Biological Studies who is redirecting gene-editing technology to target dementia has been named toMIT Technology Review’s annual list of Innovators Under 35.
Conditions Improve for Proton Therapy Center
Facility Sees Uptick in Patients, Evolving Insurance Status
San Diego’s only proton therapy center has reported higher patient volumes following a campaign to reach more oncology practices and insurers slowly coming around to the cancer treatment.
Prometheus Laboratories Acquired, Set to Lay off 72 Employees
San Diego subsidiary Prometheus Laboratories is slated to lay off 72 workers after being acquired by local company Precision IBD.
Prev Next